The first case of a superior sagittal sinus
Protein C is an important inhibitor of plasma coagulation and its deficiency may lead to thromboembolic events,' the most common of which occur in the venous vasculature. We report what is, to our knowledge, the first case of superior sagittal sinus thrombosis causing isolated intracranial hypertension as a result of congenital protein C deficiency.
Case report. A 60 year old housemaid, with no previous history of thrombosis, was bitten by a dog in December 1989. She was treated with oral doxycycline (200 mg) and ampicillin (1500 mg) daily. The bite healed without fever and no adenopathy. On day 5, the patient developed frontotemporal bilateral headache with nocturnal recrudescence, nausea, and drowsiness, and antibiotics were stopped. The symptoms worsened and were completed, two weeks later, by blurred vision and diplopia. When first examined in the department, the patient was awake and alert. She was found to have bilateral abducens palsy and papilloedema. There was no fever and no ear, nose and throat infection. Enhanced cerebral CT scan showed a discrete delta sign, small ventricles, and no mass effect. A right carotid angiography disclosed a thrombosis of the caudal part of the superior sagittal sinus (figure). The following blood tests were normal: erythrocyte sedimentation rate, white blood cell count, red blood cell count, electrolytes, glucose, creatinine, protein electrophoresis, complement, and antinuclear antibodies. Serological reactions were negative for Treponema pallidum, HIV 1 and 2, Borrelia burgdorferi, Coxiella Protein C is a vitamin K dependent protein synthesised in the liver and activated by thrombin and thrombomodulin.' In collaboration with protein S, another vitamin K dependent factor, protein C inactivates cofactors Va and VIIIIa, which exert a procoagulant effect through activated factor X and thrombin, respectively. Protein C deficiency has been described in association with thromboembolic events in the venous vasculature, notably, limb thrombophlebitis, recurrent superficial thrombophlebitis that is considered as particularly suggestive of the condition, pulmonary embolism, and other deep venous thromboses.' 4 It is found in 4% to 8% of venous thrombosis cases occurring before the age of 40.4 More recently, it has been noticed in non-haemorrhagic arterial stroke.6 Two types of protein C deficiency have been described: type I, with a reduction of both antigen concentration and activity of protein C, and type II, with reduction of activity but normal antigen level. Acquired causes of protein C deficiency are liver cirrhosis, leukaemia, disseminated intravascular coagulation, and treatments with antineoplastic drugs or vitamin K antagonists.' Protein C deficiency may also be congenital with a mode of inheritance thought to be autosomal dominant. The heterozygous state is usually asymptomatic and its estimated prevalence is 1 in 200 to 300 according to a prospective study from 5422 normal adults.7 Additional thromboembolic factors might be necessary for thrombotic manifestations to appear.78
In our case, protein C deficiency is presumably congenital as acquired causes could be excluded and assessments of the protein concentration and activity were consistently found below the lower limit of the normal range during the follow up ( 12 recently presented a similar case but the presentation was not strictly isolated intracranial hypertension and it was found during the postpartum period. To our knowledge, our case is the first to be reported with a typical isolated intracranial hypertension presentation revealing a protein C deficiency. No alternative aetiological explanation has been found for the angiographically demonstrated superior sagittal sinus thrombosis. Our patient had received doxycycline for the first time in her life, however, at the onset of her disease. Thirteen cases of association between isolated intracranial hypertension and tetracyclines have been reported previously in adults."3'9 Among the seven that were studied angiographically, none showed a cerebral venous thrombosis. Furthermore, tetracyclines are not known to interfere with coagulation. We might speculate that the therapy with doxycycline favoured the isolated intracranial hypertension clinical presentation for the cerebral venous thrombosis in our patient, but the classic association between antibiotic intake and isolated intracranial hypertension has recently been challenged. 20 In conclusion, this case report confirms that protein C deficiency may lead to cerebral venous thrombosis and shows for the first time that the clinical expression may be of the isolated intracranial hypertension type. Furthermore, it gives another example of the importance of (a) a systematic morphological examination of the cerebral venous sinuses by angiography2l or MRI in the aetiological expertise of isolated intracranial hypertension; and (b) a complete coagulation screening in cases of cerebral venous thrombosis, even when routine coagulation tests are normal. This strategy may be of the utmost practical relevance. In cases of thrombosis attributed to congenital protein C deficiency, anticoagulants are indicated but cautious starting is required as skin necrosis may develop.' Protein C half life is shorter than that of other vitamin K dependent coagulation factors and its plasma concentration decreases more rapidly in response to vitamin K antagonists with thrombosis as a result. Loading doses of vitamin K antagonists must be avoided in such patients and concurrent heparin administration must be maintained as long as the vitamin K antagonist has not reached its full effectiveness as determined by the appropriate coagulation tests. Lastly, lifelong treatment with vitamin K antagonists may be advocated in patients with thrombotic events and congenital protein C deficiency as well as in their asymptomatic heterozygotic rela- 
